JNPMEDI participated in the 2023 American Society of Clinical Oncology (ASCO) Korean Pavilion exhibition booth.
JNPMEDI
JNPMEDI, a company specializing in clinical trial data management solutions, has announced that it will participate in the 2023 ASCO (American Society of Clinical Oncology), the world's largest cancer society, to be held in Chicago, USA from June 2 to June 6, 2023.
ASCO 2023
JNPMEDI, a company specializing in clinical trial data management solutions, has announced that it will participate in the 2023 ASCO (American Society of Clinical Oncology), the world's largest cancer society, to be held in Chicago, USA from June 2 to June 6, 2023.
At this event, JNPMEDI is the only medical data solution company participating in the exhibition booth of the Korean Pavilion. It will showcase its globally recognized clinical trial data management technology and innovation at ASCO. Through this, it plans to secure opportunities to expand business areas linked to the global medical market and enhance brand competitiveness.
JNPMEDI plans to strengthen its plan to enter the global clinical trial market and expand its global influence based on cooperation with global medical institutions and pharmaceutical companies, taking the opportunity of participating in the ASCO Korean Pavilion. In addition, it plans to further accelerate the advancement of Maven Clinical Cloud.
JNPMEDI currently provides various clinical trial data management and analysis solutions by combining advanced medical technology and information systems. Through this, JNPMEDI supports the research and development of domestic and foreign medical institutions and pharmaceutical companies, and secures a competitive position in the global medical market.